Universal Vision Biotechnology Co., Ltd. (TPEX:3218)
133.50
0.00 (0.00%)
Aug 19, 2026, 9:29 AM CST
TPEX:3218 Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 4,274 | 4,204 | 4,228 | 4,082 | 3,494 | 2,632 |
Revenue Growth | 0.24% | -0.57% | 3.58% | 16.83% | 32.76% | 28.18% |
Gross Profit Gross Profit Growth | 2,487 | 2,483 | 2,533 | 2,448 | 2,140 | 1,636 |
Operating Income Operating Income Growth | 1,335 | 1,380 | 1,398 | 1,312 | 1,081 | 768.54 |
Net Income Net Income Growth | 1,145 | 1,043 | 1,065 | 1,045 | 850.53 | 595.43 |
Earnings Per Share EPS Growth | 13.46 | 12.26 | 12.53 | 12.31 | 10.02 | 7.02 |
EPS Growth | 28.89% | -2.15% | 1.79% | 22.85% | 42.76% | 23.22% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Medical Operations Department Medical Operations Department Growth | 3,259 | 3,441 | 3,472 | 2,751 | 2,248 |
Optical Operation Department Optical Operation Department Growth | 1,093 | 995.97 | 880.79 | 742.82 | 619 |
Adjustment and Elimination Adjustment and Elimination Growth | -147.8 | -208.48 | -270.87 | - | -235.27 |
Total Total Growth | 4,204 | 4,228 | 4,082 | 3,494 | 2,632 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,029 | 2,103 | 1,917 | 1,641 | 1,280 | 1,040 |
Total Debt Total Debt Growth | 1,508 | 1,063 | 1,054 | 778.26 | 783.65 | 767.53 |
Net Cash (Debt) Net Cash Growth | -478.92 | 1,040 | 863.2 | 862.65 | 495.99 | 272.47 |
Net Cash Growth | - | 20.47% | 0.07% | 73.92% | 82.03% | -41.23% |
Net Cash Per Share Net Cash Per Share Growth | -5.63 | 12.23 | 10.16 | 10.16 | 5.85 | 3.21 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 1,778 | 1,666 | 1,672 | 1,554 | 1,268 | 911.77 |
Capital Expenditures CapEx Growth | -470.58 | -562.66 | -434.65 | -472.53 | -489.7 | -324.44 |
Free Cash Flow Free Cash Flow Growth | 1,307 | 1,104 | 1,237 | 1,081 | 778.47 | 587.33 |
Free Cash Flow Growth | 5.03% | -10.80% | 14.46% | 38.87% | 32.55% | 10.41% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 58.19% | 59.05% | 59.91% | 59.98% | 61.24% | 62.18% |
Operating Margin | 31.24% | 32.83% | 33.06% | 32.14% | 30.94% | 29.20% |
Pretax Margin | 33.15% | 32.01% | 31.17% | 32.30% | 31.26% | 29.00% |
Profit Margin | 26.78% | 24.80% | 25.18% | 25.60% | 24.34% | 22.62% |
FCF Margin | 30.58% | 26.25% | 29.27% | 26.48% | 22.28% | 22.32% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 7.750 | 7.750 | 7.500 | 7.000 | 5.660 | 4.492 |
Dividend Per Share Growth | 3.33% | 3.33% | 7.14% | 23.67% | 26.00% | 19.05% |
Dividend Yield | 5.74% | 5.62% | 4.11% | 2.84% | 2.30% | 2.06% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 9.92 | 11.86 | 15.92 | 22.46 | 28.05 | 36.18 |
Forward PE | 9.64 | 10.66 | 15.24 | 19.41 | 24.67 | 27.75 |
P/FCF Ratio | 8.65 | 11.21 | 13.69 | 21.71 | 30.65 | 36.68 |
PS Ratio | 2.65 | 2.94 | 4.01 | 5.75 | 6.83 | 8.19 |